Skip to main content

Table 6 Postoperative complications in both groups

From: Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma

 

Injection Group

Control Group

P

Anterior uveitis

7 (33.3 %)

10 (47.6 %)

0.42

Worsened corneal edema

2 (9.5 %)

2 (9.1 %)

0.96

Hyphema

9 (42.9 %)

9 (40.9 %)

0.90

Vitreous hemorrhage

2 (9.5 %)

5 (22.7 %)

0.23

Transient ocular hypertension

2 (9.5 %)

4 (18.2 %)

0.41

Malignant glaucoma

0

0

 

Sustained low IOP

0

0

 

Drainage tube obstruction/displacement/exposure

3 (14.3 %)

4 (18.2 %)

0.73

Lens opacity

1 (4.8 %)

0

 

Choroidal hemorrhage/detachment

0

1 (4.5 %)

 

Retinal detachment

0

0

 

Conjunctival retraction/rupture

0

1 (4.5 %)

 

Endophthalmitis

0

0

 

Loss of light perception

0

0

 

Total

12 (57.1 %)

14 (63.6 %)

0.66

  1. Note: The differences in postoperative complications were compared between the two groups using the chi-square or corrected chi-square test